An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cell Metabolism

• Publication date

  2018-03-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.cmet.2018.01.005PMID 29456073PMCID PMC6706084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DIABLO: from multi-omics assays to biomarker discovery, an integrative approach

  2018cited by this paper
• Regulation of hepatic glucose metabolism in health and disease

  2017cited by this paper
• Role of folate in nonalcoholic fatty liver disease.

  2017cited by this paper
• Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota

  2017cited by this paper
• Visualization of Regression Models Using visreg

  2017cited by this paper
• One-Carbon Metabolism in Health and Disease.

  2017cited by this paper
• A wellness study of 108 individuals using personal, dense, dynamic data clouds

  2017cited by this paper
• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

  2017cited by this paper
• Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

  2017cited by this paper
• Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults.

  2017cited by this paper
• Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

  2017cited by this paper
• Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.

  2016cited by this paper
• The role of the gut microbiota in NAFLD

  2016influential reference
• Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.

  2016cited by this paper
• Therapy: Positioning of dilation in eosinophilic oesophagitis

  2016cited by this paper
• Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

  2016cited by this paper
• The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue

  2016cited by this paper
• Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients

  2016cited by this paper
• Near-optimal probabilistic RNA-seq quantification

  2016cited by this paper
• Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance.

  2016cited by this paper
• Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism.

  2015cited by this paper
• Transcriptional regulation of hepatic lipogenesis

  2015influential reference
• Differences in folate production by bifidobacteria of different origins

  2015cited by this paper
• Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization

  2015cited by this paper
• Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples

  2015cited by this paper
• Linking Microbiota to Human Diseases: A Systems Biology Perspective.

  2015cited by this paper
• Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.

  2015cited by this paper
• Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

  2015cited by this paper
• Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.

  2015cited by this paper
• Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease

  2014cited by this paper
• Fitting Linear Mixed-Effects Models Using lme4

  2014cited by this paper
• FGF21 is an endocrine signal of protein restriction.

  2014cited by this paper
• Integrated physiology and systems biology of PPARα

  2014cited by this paper
• Metagenomic Data Utilization and Analysis (MEDUSA) and Construction of a Global Gut Microbial Gene Catalogue

  2014cited by this paper
• Effects of dietary interventions on liver volume in humans

  2014cited by this paper
• Calorie restriction and Roux‐en‐Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Integration of clinical data with a genome-scale metabolic model of the human adipocyte

  2013cited by this paper
• Diet rapidly and reproducibly alters the human gut microbiome

  2013influential reference
• Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.

  2013cited by this paper
• Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology

  2013cited by this paper
• Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione

  2013cited by this paper
• Microbial modulation of energy availability in the colon regulates intestinal transit.

  2013cited by this paper
• phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data

  2013cited by this paper
• Folate deficiency enhances the inflammatory response of macrophages.

  2013influential reference
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

  2013cited by this paper
• Personal omics profiling reveals dynamic molecular and medical phenotypes.

  2012cited by this paper
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012influential reference
• Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

  2012cited by this paper
• Interstrain differences in the severity of liver injury induced by a choline‐ and folate‐deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism

  2012cited by this paper
• Role of cytokines and chemokines in non-alcoholic fatty liver disease.

  2012cited by this paper
• Nutritional deficiencies after bariatric surgery

  2012cited by this paper
• Long‐TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat

  2011cited by this paper
• Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

  2011cited by this paper
• B‐Group vitamin production by lactic acid bacteria – current knowledge and potential applications

  2011influential reference
• Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

  2011cited by this paper
• Plasmalogens the neglected regulatory and scavenging lipid species.

  2011cited by this paper
• Folate Production by Probiotic Bacteria

  2011cited by this paper
• Differential expression analysis for sequence count data

  2011cited by this paper
• Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.

  2011cited by this paper
• Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

  2010cited by this paper
• Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism.

  2010cited by this paper
• Long‐term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients

  2010influential reference
• Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man

  2010cited by this paper
• Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

  2010influential reference
• Gene ontology analysis for RNA-seq: accounting for selection bias

  2010cited by this paper
• Differential expression analysis for sequence count data

  2010cited by this paper
• Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

  2010cited by this paper
• Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-labeled [6S]-5-formyltetrahydrofolic acid.

  2009cited by this paper
• A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.

  2009cited by this paper
• Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

  2009cited by this paper
• Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

  2009cited by this paper
• Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation

  2009cited by this paper
• MuMIn : multi-model inference, R package version 0.12.0

  2009cited by this paper
• Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

  2008cited by this paper
• Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity.

  2008cited by this paper
• Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr Published, JLR Papers in Press, November 18, 2007.

  2008cited by this paper
• Quantification of Folic Acid in Human Feces After Administration of Bifidobacterium Probiotic Strains

  2008cited by this paper
• Causes and metabolic consequences of Fatty liver.

  2008cited by this paper
• Inaugural Article: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome

  2007influential reference
• Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry.

  2007cited by this paper
• Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

  2007cited by this paper
• Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces

  2006cited by this paper
• A low‐carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content

  2006cited by this paper
• Tree diversity analysis: a manual and software for common statistical methods for ecological and biodiversity studies

  2006cited by this paper
• The metabolic response to a high-protein, low-carbohydrate diet in men with type 2 diabetes mellitus.

  2006cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005influential reference
• "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.

  2005cited by this paper
• Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.

  2005cited by this paper
• Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver.

  2005cited by this paper
• A large pool of available folate exists in the large intestine of human infants and piglets.

  2004cited by this paper
• Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?

  2004cited by this paper
• Dietary Composition and Nonalcoholic Fatty Liver Disease

  2004cited by this paper
• Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.

  2003cited by this paper
• A randomized trial of a low-carbohydrate diet for obesity.

  2003cited by this paper
• Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig

  2002cited by this paper
• Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.

  2002cited by this paper
• KEGG: Kyoto Encyclopedia of Genes and Genomes

  2000cited by this paper
• Folates - food sources, analyses, retention and bioavailability

  1999cited by this paper

• The value of targeting ketone body metabolism in inflammatory and autoimmune diseases.

  2026cites this paper
• Metabolite-mediated crosstalk: unraveling the interactions between gut microbiota and host in fatty liver hemorrhagic syndrome of laying hens

  2026cites this paper
• Impacts of ketogenic diet intervention on cardiometabolic outcomes in obese, dysglycemic mice

  2026cites this paper
• Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target

  2026cites this paper
• The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review

  2026cites this paper
• Soybean genistin-driven gut microbiota-derived butyrate synthesis activates the Sirt1 signaling pathway to ameliorate metabolic fatty liver.

  2025cites this paper
• Time-restricted eating and circadian rhythms: A new frontier in diabetes and obesity management.

  2025cites this paper
• Halting Hypercaloric Feeding in Liver Chimeric Mice Rapidly Resolves Human Hepatocyte Steatosis

  2025cites this paper
• Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism

  2025cites this paper
• Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes

  2025influential citation
• Ketogenic diet ameliorates MASLD via balancing mitochondrial dynamics and improving mitochondrial dysfunction

  2025cites this paper
• Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital

  2025cites this paper
• Carbohydrate-restricted diet types and macronutrient replacements for metabolic health in adults: A meta-analysis of randomized trials.

  2025cites this paper
• Therapeutic Carbohydrate Reduction for Lipedema: Guidelines for a Patient-Centered, Holistic Approach

  2025cites this paper
• New Frontiers in Nutritional and Therapeutic Interventions for Obesity Phenotypes

  2025cites this paper
• Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.

  2025cites this paper
• Effects of Acute Iso- and Hypocaloric Carbohydrate Restriction on Liver Fat and Glucose and Lipid Metabolism

  2025cites this paper
• Temporal response patterns of human gut microbiota to dietary fiber

  2025cites this paper
• The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis

  2025cites this paper
• ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet.

  2025cites this paper
• The Effect of Intermittent Fasting Diet in Comparison With Low-Calorie Diet on Inflammation, Lipid Profile, Glycemic Index, Liver Fibrosis in Patients With Metabolic-Associated Fatty Liver Disease (MAFLD): A Randomized Controlled Trial.

  2025cites this paper
• A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

  2025cites this paper
• Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis

  2025cites this paper
• Ketogenic diets and metabolic dysfunction-associated steatotic liver disease: a literature review

  2025influential citation
• Paternal Folic Acid Supplementation Alleviated Hepatic Steatosis in Male Offspring Through Sperm DNA Methylation Modification

  2025cites this paper
• The impact of very-low-calorie ketogenic diets on gut microbiota in individuals with obesity: a systematic review and meta-analysis

  2025cites this paper
• Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery

  2025cites this paper
• Multi-omics-driven kinetic modeling reveals metabolic adaptations and vulnerabilities in BRCA1-deficient ovarian cancer

  2025cites this paper
• MASH: the nexus of metabolism, inflammation, and fibrosis

  2025cites this paper
• A novel ketogenic diet that reduces seizures and prevents liver steatosis leads to related gut microbiome changes and restores cecal short-chain fatty acid levels in the rapid kindling rat model of epileptogenesis

  2025cites this paper
• Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism

  2025cites this paper
• Human Digestive Physiology and Evolutionary Diet: A Metabolomic Perspective on Carnivorous and Scavenger Adaptations

  2025cites this paper
• Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease—the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Evidence-based review of the nutritional treatment of obesity and metabolic dysfunction-associated steatotic liver disease in children and adolescents.

  2025cites this paper
• Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement

  2025cites this paper
• Microbiota fasting-related changes ameliorate cognitive decline in obesity and boost ex vivo microglial function through the gut-brain axis

  2025cites this paper
• Bacterial metabolic signatures in MASLD predicted through gene-centric studies in stool metagenomes

  2025cites this paper
• Simulated gut microbiota fermentation of polysaccharide extracts from Ganoderma lucidum and Ganoderma neo-japonicum.

  2025cites this paper
• Carbohydrate Deprivation Improves Glycolipid Metabolism and Activates AMPK/PGC1α Signaling Pathway in Mice

  2025cites this paper
• Unveiling the Prebiotic Properties of Mushrooms in Improving Gut Health and Related Diseases

  2025cites this paper
• A Gastroenterologist's Approach to Improving Metabolic Health in MASLD.

  2025cites this paper
• Precision Dietary Intervention: Gut Microbiome and Meta-metabolome as Functional Readouts

  2025cites this paper
• The Influence of Physical Exercise, Ketogenic Diet, and Time-Restricted Eating on De Novo Lipogenesis: A Narrative Review

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025

  2025cites this paper
• Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

  2025cites this paper
• MASLD: insights on the role of folate in hepatic lipid metabolism

  2025cites this paper
• Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response

  2025cites this paper
• Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease.

  2024cites this paper
• The Influence of Dietary Patterns on Immune Function and Inflammation

  2024cites this paper
• Fibre & fermented foods: differential effects on the microbiota-gut-brain axis.

  2024cites this paper
• The Impact of a Ketogenic Diet on Late-Stage Pancreatic Carcinogenesis in Mice: Efficacy and Safety Studies

  2024cites this paper
• Ex Vivo Demonstration of a Novel Dual-Frequency Ultrasound Method for Quantitative Measurements of Liver Fat Content.

  2024cites this paper
• Targeting ketone body metabolism to treat fatty liver disease

  2024cites this paper
• Tea (Camellia sinensis L.) flower polysaccharide attenuates metabolic syndrome in high-fat diet induced mice in association with modulation of gut microbiota.

  2024cites this paper
• Digesting the complex metabolic effects of diet on the host and microbiome.

  2024cites this paper
• From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers

  2024cites this paper
• Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.

  2024cites this paper
• Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis

  2024influential citation
• The genetically predicted causal associations between circulating 3-hydroxybutyrate levels and malignant neoplasms: A pan-cancer Mendelian randomization study.

  2024cites this paper
• Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity

  2024cites this paper
• Role of Folate in Liver Diseases

  2024cites this paper
• Dietary patterns interfere with gut microbiota to combat obesity

  2024cites this paper
• Systematic identification of secondary bile acid production genes in global microbiome

  2024cites this paper
• Nutritional Considerations During Major Weight Loss Therapy: Focus on Optimal Protein and a Low-Carbohydrate Dietary Pattern

  2024cites this paper
• Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes, Neurodegeneration, and Oncology

  2024cites this paper
• The function and application of edible fungal polysaccharides.

  2024cites this paper
• The Impact of Short-term Eucaloric Low-Carbohydrate and High-Carbohydrate Diet on Liver Triacylglycerol Content in Males with Overweight and Obesity; a Randomized Cross-Over Study.

  2024cites this paper
• Ketogenic diet time-dependently prevents NAFLD through upregulating the expression of antioxidant protein metallothionein-2.

  2024cites this paper
• Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial

  2024cites this paper
• Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions

  2024cites this paper
• Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective

  2024cites this paper
• Gut microbiota in MAFLD: therapeutic and diagnostic implications

  2024cites this paper
• CMS121: a novel approach to mitigate aging-related obesity and metabolic dysfunction

  2024cites this paper
• A unified framework for prediction of liver steatosis dynamics in response to different diet and drug interventions.

  2024cites this paper
• Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption

  2024influential citation
• Strain-specific responses of Penaeus vannamei to two Enterococcus faecium strains supplementation: A trade-off between growth and immunity

  2024cites this paper
• Precision Nutrition Unveiled: Gene–Nutrient Interactions, Microbiota Dynamics, and Lifestyle Factors in Obesity Management

  2024cites this paper
• Triggers for the onset and recurrence of psoriasis: a review and update

  2024cites this paper
• Letter-to-the-editor on “A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice”

  2024influential citation
• Impact of dietary carbohydrate, fat, or protein restriction on the human gut microbiome: a systematic review.

  2024cites this paper
• Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis

  2024cites this paper
• Altered lipid metabolism and the development of metabolic-associated fatty liver disease

  2024cites this paper
• Moderate variations in the human diet impact the gut microbiota in humanized mice

  2024cites this paper
• Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning

  2024cites this paper
• Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases

  2024cites this paper
• The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease

  2024cites this paper
• The impact of ketogenic diet on some metabolic and non‐metabolic diseases: Evidence from human and animal model experiments

  2024cites this paper
• Navigating the B vitamins: Dietary diversity, microbial synthesis, and human health.

  2024cites this paper
• System biology approaches for drug repurposing.

  2024cites this paper
• High diversity, close genetic relatedness, and favorable living conditions benefit species co-occurrence of gut microbiota in Brandt’s vole

  2024cites this paper
• A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity

  2024cites this paper
• Research advances in the diagnosis and treatment of MASLD/MASH

  2024cites this paper
• A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China

  2024cites this paper
• Integrative regulation of hLMR1 by dietary and genetic factors in nonalcoholic fatty liver disease and hyperlipidemia

  2024cites this paper
• Role of folic acid in regulating gut microbiota and short-chain fatty acids based on an in vitro fermentation model

  2024cites this paper
• Metagenomic and metabolomic analysis showing the adverse risk–benefit trade-off of the ketogenic diet

  2024cites this paper
• Functional roles of folic acid in alleviating dexamethasone‐induced fatty liver syndrome in laying hens

  2024cites this paper
• High sucrose diet-induced abnormal lipid metabolism in mice is related to the dysbiosis of gut microbiota.

  2024cites this paper
• Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions

  2023cites this paper